0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Detection Methods Human Health Effects Policy & Risk Sign in to save

Per- and Polyfluoroalkyl Substances (PFAS) as Emerging Obesogens: Mechanisms, Epidemiological Evidence, and Regulatory Challenges

Physiologia 2024 10 citations ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count.
Ned Lewis, Abubakar Abdulkadir, Sandhya Neupane Kandel, Raphyel Rosby, Ekhtear Hossain

Summary

This review examines growing evidence that PFAS, the 'forever chemicals' found in many consumer products, may act as obesogens, meaning they could promote obesity by disrupting hormones and fat metabolism. PFAS exposure has been linked to changes in how the body stores fat and processes lipids, with some studies suggesting maternal exposure may increase obesity risk in children. While focused on PFAS rather than microplastics, the findings are relevant because both are persistent environmental pollutants that can act as endocrine disruptors.

Body Systems
Models
Study Type In vivo

The pervasive presence of per- and polyfluoroalkyl substances (PFAS) in the environment and their persistent nature raise significant concerns regarding their impact on human health. This review delves into the obesogenic potential of PFAS, shedding light on their mechanisms of action, epidemiological correlations with obesity and metabolic disorders, and the challenges faced in regulatory frameworks. PFAS, characterized by their carbon-fluorine chains, are ubiquitous in various consumer products, leading to widespread exposure through ingestion of contaminated food and water. Emerging evidence suggests that PFAS may act as endocrine-disrupting chemicals, interfering with lipid metabolism and hormone functions related to obesity. We examine in vitro, in vivo, human, and in silico studies that explore the interaction of PFAS with PPARs and other molecular targets, influencing adipogenesis and lipid homeostasis. Furthermore, the review highlights epidemiological studies investigating the association between maternal PFAS exposure and the risk of obesity in offspring, presenting mixed and inconclusive findings that underscore the complexity of PFAS effects on human health. Presently, there are major challenges in studying PFAS toxicity, including their chemical diversity and the limitations of current regulatory guidelines, potential remediation, and detoxification. This review emphasizes the need for a multidisciplinary approach, combining advanced analytical methods, in silico models, and comprehensive epidemiological studies, to unravel the obesogenic effects of PFAS and inform effective public health strategies.

Share this paper